Drugs / ACTH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02315872 | May 2015 → Jun 2017 | relapsing-remitting multiple sclerosis | Providence Health & Services | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02315872 ↗ |
| Route | Subcutaneous | “will be given subcutaneously” NCT02315872 ↗ |